Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
If you want minimal turnover, this guide highlights index funds with the least turnover and how to assess them for your portfolio.
27,312 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Tilray Brands is targeting a milestone $1.2 billion in annual revenue next year. This article digs into how the compa...
A new move from Google signals a shift in AI compute. This could tilt the balance away from Nvidia in certain cloud a...
When a career hits its peak, money, fame, and pressure can collide. This article uses parsons says ‘miserable’ peak a...
O-I Glass has climbed about 17% over the past year, even as a large fund unloaded roughly $80 million worth of stock....
A celebrity crisis can hit finances in surprising ways. This hypothetical look at the 44-year-old superstar britney s...
A high-profile legal battle claims a $175 million loss across jewelry, real estate, and jet deals. This piece breaks ...
The AI boom has people wondering if could buying crypto today could lead to life-changing gains. This article breaks ...
The latest trustees report signals coming pressures on Social Security. This guide breaks down what that means for ev...
As year-end approaches, investors are hunting for a tech stock with durable AI-driven growth and solid cash flow. Thi...
Ark Invest’s latest stance on quantum computing raises questions for Rigetti Computing. This guide breaks down the im...
Institutional moves shape the AI stock landscape. This article dives into Philippe Laffont’s Coatue strategy, why Nvi...